Detalhe da pesquisa
1.
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations.
Br J Haematol
; 195(1): 76-84, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159588
2.
Multiple myeloma with central nervous system relapse.
Haematologica
; 105(7): 1780-1790, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414852
3.
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1993-2001, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229641
4.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716453
5.
Ethical implications of digital communication for the patient-clinician relationship: analysis of interviews with clinicians and young adults with long term conditions (the LYNC study).
BMC Med Ethics
; 19(1): 11, 2018 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29475437
6.
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
Biol Blood Marrow Transplant
; 22(1): 71-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256940
7.
A severe bleeding diathesis in a 6-year-old girl secondary to a composite diagnosis of splenic hemangiomatosis and small bowel lymphangiomatosis.
J Pediatr Hematol Oncol
; 36(5): 404-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24136025
8.
Impact of chronic graft-versus-host disease on non-relapse mortality and survival.
Leuk Lymphoma
; : 1-8, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38865104
9.
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.
Leuk Lymphoma
; 64(7): 1315-1321, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199099
10.
Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia.
Br J Haematol
; 159(1): 82-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22831395
11.
Survival, response rates, and post-transplant outcomes in patients with Acute Myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy.
Front Oncol
; 12: 1017194, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263213
12.
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience.
Cancers (Basel)
; 14(9)2022 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565406
13.
Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma.
Transplant Cell Ther
; 28(6): 342.e1-342.e5, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248778
14.
IgD multiple myeloma: biology, diagnosis, and treatment.
Leuk Lymphoma
; 63(14): 3433-3437, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263946
15.
Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma.
J Clin Med
; 11(19)2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233663
16.
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant.
Front Oncol
; 12: 801879, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280722
17.
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience.
Cancers (Basel)
; 14(22)2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428678
18.
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.
Hematol Oncol
; 29(4): 202-10, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21360728
19.
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS.
Leuk Lymphoma
; 62(4): 944-951, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231122
20.
Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation.
J Clin Med
; 10(13)2021 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199028